Click here for more information about Algenuity
Click here for more information about LiqofluxPhenometrics Buy 3 Get 1 Free
Visit cricatalyst.com!Evodos Separation Technology

Research

Marine algae to reduce antibiotics in farming

March 10, 2016
AlgaeIndustryMagazine.com

olmix_and_inraAs part of a partnership in France with the Olmix Group, researchers from Inra Val de Loire Infectiology and Public Health Research Centre (Inra) have shown that a compound extracted from green algae inhibited the growth of pathogenic bacteria in vitro and stimulated the production of immunity mediators by intestinal epithelial cells. This type of preparation could be used in livestock feed to improve animals’ resistance to infections and therefore reduce the use of antibiotics. It could also be used as an aid in vaccine strategies. These results were published on March 8, 2016 in the Journal of Applied Phycology.

Marine algae are chlorophyll-containing aquatic plants that grow on the seabed. They are classified in three groups depending on their pigments: brown algae (phaeophyceae), red algae (rhodophyceae) and green algae (chlorophyceae or ulvales). The cell wall of these marine algae are rich in sulfated polysaccharides, which possess physicochemical and biological properties that could have potential applications in the pharmaceutical industry, biomedicine, cosmetology and farming, or as additives in human and animal food.

Created in 1995, Olmix Group is specialized in promoting the use of green algae harvested in France’s Brittany region by processing them into innovative natural products for plant, animal and human nutrition and health sectors. With the aim of identifying beneficial bioactive molecules, Olmix Group prepared an extract of sulphated polysaccharide known as marine sulphated polysaccharides (MSP), using Ulva armoricana green marine algae harvested in Brittany.

For the Olmix / Inra research project, an MSP was studied in vitro to test its capacity to inhibit bacterial growth and stimulate the production of immunity mediators. The MSP’s ability to inhibit bacterial growth was observed on a panel of 42 strains of pathogenic bacteria isolated from livestock or their environment. MSP also induced an increased production of cytokines, in an in vitro system of differentiated porcine intestinal epithelial cells. The stimulation of these immune mediators indicated a potential stimulation of intestinal immunity by MSP.

Marine algae represent a source of natural bioactive molecules (including MSPs), which could be used in livestock feed to inhibit the growth of pathogens and boost the immune response. This could improve animals’ resistance to infections and reduce the use of antibiotics on farms.

Inra and Olmix are pursuing their partnership to determine the MSP’s mechanism of action, identify the cell receptors involved in recognizing MSP and confirm the in vitro results within vivo testing.

Mustapha Berri, Cindy Slugocki, Michel Olivier, Emmanuelle Helloin, Isabelle Jacques, Henri Salmon, Hervé Demais, Matthieu Le Goff, and Pi Nyvall Collen contributed to this research.

More Like This…

Copyright ©2010-2019 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Judith Lewis Mernit writes in e360.yale.edu that an experiment being conducted by animal science professor Ermias Kebreab at the University of California, Davis, is testi...
42 Technology has been appointed by LabXero, acoustic particle filtration technology company, to help develop pilot-scale biomanufacturing equipment that could significan...
Milenio.com reports that BiomiTech, a Mexican company, won a prestigious innovation award for its air purification system at the Contamination Expo Series 2018 held in Bi...
JapanNews.com reports that Euglena Co., a Tokyo-based maker of nutritional supplements, is spending ¥5.8 billion ($5.3 million USD) on building a test refinery that conve...
Dartmouth scientists have created a more sustainable feed for aquaculture by using a marine microalga co-product as a feed ingredient. The study is the first of its kind ...
French researchers have been exploring the potential of algae for boosting the immune systems of animals and reducing the use of antibiotics in livestock farming. Past st...
Paris-based Solabia Group (“Solabia”) has acquired Algatech Ltd., a global leader in the development, cultivation and commercialization of ingredients delivered from micr...
Foodbev.com reports that French marine ingredients company Algaia will install a new specialty seaweed extract unit at its facility in Brittany, France, after securing €4...
Baillargues, France’s Microphyt, a leading company in microalgae-based natural solutions for nutrition and well-being, has announced a fundraising of €28.5 million (US$32...
Mazda U.K. has announced that they are currently involved in joint research projects and studies as part of an ongoing industry-academia-government collaboration to promo...
Researchers at Los Alamos National Laboratory and partner institutions have provided the first published report of algae using raw plants as a carbon energy source. The r...
Alexander Richter reports for Geothermal Energy News that, among the many examples offered during a recent conference in Pisa, Italy, on Perspectives and Impact of the Gr...